Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review
Simone Pardossi, Andrea Fagiolini, Alessandro Cuomo · 2024
Read Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review by Simone Pardossi, Andrea Fagiolini, Alessandro Cuomo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642200.txt.
Description
Simone Pardossi, Andrea Fagiolini, and Alessandro Cuomo wrote this review paper, published in 2024. It asks what role a brain protein called BDNF plays in how the drugs ketamine and esketamine lift depression so fast.
BDNF helps brain cells grow, connect, and survive, and its levels run low in key brain areas of people with depression. Older antidepressants raise BDNF slowly. Ketamine and its close cousin esketamine act within hours, and animal work points to BDNF as part of that effect. Human results are mixed, though: most studies find blood BDNF rises after ketamine given by vein, but some do not. Very few studies cover esketamine. The authors call for larger studies to settle the question.
Catalog record
| CREATOR | Simone Pardossi, Andrea Fagiolini, Alessandro Cuomo |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |